In the context of the CNS, CYLD’s role in the regulation of NF-κB could have various implications and may contribute to NF-κB’s action in neurodegenerative and neuroinflammatory diseases such as Alzheimer’s, Parkinson’s, and multiple sclerosis [14]. Here, NFKB1 is linked to Parkinsonism.